Saturday, May 31, 2025

Latest

JUUL Slapped with FDA Warning Letter for Health Claims

JUUL Labs, an e-cigarette products company that is 35% owned by Altria (NYSE: MO) and an expected partner of Cronos Group (TSX: CRON)(NASDAQ: CRON), was slapped with an FDA warning letter this morning as a result of its advertising and marketing practices which contain unsubstantiated claims related to the health benefits of vaping using JUUL products over that of smoking traditional cigarettes.

Specifically, the claims were found as a result of a hearing at a House Subcommittee focused on “Examining JUUL’s Role in the Youth Nicotine Epidemic.” In particular, it found that numerous claims were told to youth by JUUL sales representatives during sales pitches and presentations including,

  • A JUUL representative speaking with students at his presentation stated that JUUL “was much safer than cigarettes” and that “FDA would approve it any day.”
  • The JUUL representative speaking with students at his presentation called JUUL “totally safe.”
  • The JUUL representative speaking with students at his presentation stated that a student “…should mention JUUL to his [nicotine-addicted] friend…because that’s a safer alternative than smoking cigarettes, and it would be better for the kid to use.
  • The JUUL representative speaking with students at his presentation stated, “FDA was about to come out and say it [JUUL] was 99% safer than cigarettes…and that…would happen very soon….”

In addition, the FDA cited that JUUL was in violation of a number of marketing related misrepresentations of its products.

“…your firm has engaged in labeling, advertising, and/or other activities directed to consumers, in which JUUL explicitly and/or implicitly has represented that JUUL products are free of a substance, have a reduced level of or exposure to a substance, and/or that JUUL products present a lower risk of tobacco-related disease or are less harmful than one or more other commercially marketed tobacco products.”

Certain of the presentations were found to have been conducted directly in schools, wherein JUUL stated that using its products were “99% safer than cigarettes.”

The FDA finalized its letter by stating that an exhaustive list was not necessary included in the letter, and that failure to make corrections could result in “FDA initiating further action, including, but not limited to, civil money penalties, seizure, and/or injunction.”

JUUL has fifteen days to make corrections to its marketing programs, as well as to provide a written response to the FDA on the actions it has taken to correct the problems.

The full letter issued by the FDA to JUUL Labs can be found here.


Information for this briefing was found via the FDA. The author has no securities or affiliations related to any organization discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

ESGold Begins Concentration Tests Ahead Of First Production

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

Related News

FDA Gives Elon Musk’s Neuralink Approval To Test On Human Brains While Animal Harm Reports Still Loom

Elon Musk’s brain-implant firm Neuralink announced that the Food and Drug Administration (FDA) has approved...

Friday, May 26, 2023, 08:14:34 AM

Revive Files Clinical Trial Application With Health Canada, Releases Phase 3 FDA Study Design For Potential Treatment Of COVID-19

Revive Therapeutics (CSE: RVV) continues to advance its clinical trial efforts. The company announced this...

Wednesday, June 3, 2020, 11:30:38 AM

Mass Layoffs Hit FDA, CDC and Other Health Agencies

The Trump administration has initiated sweeping layoffs at key US health agencies, with approximately 10,000...

Wednesday, April 2, 2025, 02:19:00 PM

Altria’s Juul Labs Expected To Be Ordered By US FDA To Remove Products From Market

Altria (NYSE: MO) was dealt a heavy blow this morning when it was reported by...

Wednesday, June 22, 2022, 10:12:56 AM

FDA Declares Lab-Grown Chicken Safe for Human Consumption

The US Food and Drug Administration (FDA) has approved lab-grown meat for human consumption, marking...

Thursday, November 17, 2022, 04:49:26 PM